Marizomib for central nervous system-multiple myeloma

被引：62

作者：

Badros, Ashraf ^{[1
]}

Singh, Zeba ^{[1
]}

Dhakal, Binod ^{[2
]}

Kwok, Young ^{[1
]}

MacLaren, Ann ^{[3
]}

Richardson, Paul ^{[4
]}

Trikha, Mohit ^{[3
]}

Hari, Parameswaran ^{[2
]}

机构：

[1] Univ Maryland, Med Ctr, M&S Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[2] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI 53226 USA

[3] Triphase Accelerator, San Diego, CA USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 177卷 / 02期

关键词：

multiple myeloma; central nervous system relapse; clinical studies; marizomib; INVOLVEMENT;

D O I：

10.1111/bjh.14498

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Marizomib, a natural marine product, is an irreversible proteasome inhibitor currently under investigation in relapsed-refractory multiple myeloma (RRMM) and malignant glioma. Central nervous system-multiple myeloma (CNS-MM) is a rare manifestation of extra-medullary disease with few therapeutic options, highlighting the unmet clinical need in these patients. Marizomib demonstrated encouraging activity in RRMM and has emerging clinical activity in glioma, making it a potential CNS-MM therapeutic intervention. Herein, we present two patients with RRMM and CNS involvement who benefited from marizomib-based therapy. Thesecases provide the first proof of principle for further exploring marizomib in CNS-MM patients.

引用

页码：221 / 225

页数：5

共 50 条

[31] Characterization of central nervous system multiple myeloma in the era of novel therapies
Majd, Nazanin
Wei, Xiao
Demopoulos, Alexis
Hormigo, Adilia
Chari, Ajai
LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1709 - 1713
[32] Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma
Abdallah, Al-ola
Atrash, Shebli
Shahid, Zainab
Jameel, Muzaffar
Grazziutti, Monica
Apewokin, Senu
Kumar, Naveen S.
Restrepo, Alejandro
Waheed, Sarah
Van Rhee, Frits
Heuck, Christoph J.
Johann, Donald, Jr.
Barlogie, Bart
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 211 - 214
[33] Multiple myeloma and central nervous system involvement: experience of a Brazilian center
Miranda Silva Dias, Ana Luiza
Higashi, Fabiana
Peres, Ana Lucia M.
Cury, Pricilla
Crusoe, Edvan de Queiroz
de Moraes Hungria, Vania Tietsche
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (01) : 30 - 36
[34] Multiple myeloma with central-nervous-system infiltration: A case report
Xu, Mengjie
Sun, Zhihan
He, Honghua
Zhang, Yuming
ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 967 - 968
[35] Simultaneous appearance of dual malignancies of hematopoietic system-multiple myeloma and acute myeloid leukemia
Shukla, Jyoti
Patne, Shashikant C. U.
Singh, N. K.
Usha
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2008, 51 (01) : 118 - 120
[36] Extradural plasmacytoma with central nervous system involvement in newly diagnosed multiple myeloma
Satoshi Kaito
Hideharu Muto
Shunta Takebayashi
Yutaka Otsubo
Shuichi Miyawaki
Kazuteru Ohashi
International Journal of Hematology, 2017, 106 : 455 - 456
[37] Clinical features of multiple myeloma invasion of the central nervous system in Chinese patients
Qu Xiao-yan
Fu Wei-jun
Xi Hao
Zhou Fan
Wei Wei
Hou Jian
CHINESE MEDICAL JOURNAL, 2010, 123 (11) : 1402 - 1406
[38] FAMILIAL AGGREGATION OF MULTIPLE-MYELOMA AND CENTRAL NERVOUS-SYSTEM DISEASES
GRUFFERMAN, S
COHEN, HJ
DELZELL, ES
MORRISON, MC
SCHOLD, SC
MOORE, JO
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (04) : 303 - 309
[39] Extradural plasmacytoma with central nervous system involvement in newly diagnosed multiple myeloma
Kaito, Satoshi
Muto, Hideharu
Takebayashi, Shunta
Otsubo, Yutaka
Miyawaki, Shuichi
Ohashi, Kazuteru
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 455 - 456
[40] Central Nervous System Involvement in Multiple Myeloma Patients in the Era of Novel Therapies
Majd, Nazanin
Demopoulos, Alexis
Chari, Ajai
NEUROLOGY, 2013, 80

← 1 2 3 4 5 →